Qingdao Haier Biomedical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,262.68 million compared to CNY 908.16 million a year ago. Revenue was CNY 1,267.88 million compared to CNY 927.95 million a year ago.

Net income was CNY 300.57 million compared to CNY 573.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.95 compared to CNY 1.81 a year ago. Diluted earnings per share from continuing operations was CNY 0.95 compared to CNY 1.81 a year ago.